hydroxyurea - CISMeF

Preferred Label : hydroxyurea;

MeSH definition : An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.;

MeSH synonym : hydroxycarbamid;

Wikipedia automatic translation : Hydroxycarbamide;

MeSH hyponym : hydrea; oncocarbide;

MeSH CAS label : urea, hydroxy-;

MeSH Related Number : 127-07-1 (Hydroxyurea);

Registry Number MeSH : 127-07-1;

Wikipedia link : https://en.wikipedia.org/wiki/Hydroxycarbamide;

Codes EINECS : 204-821-7;

Is substance : O;

UNII : X6Q56QN5QC;

InChIKey : VSNHCAURESNICA-UHFFFAOYSA-N;

Details

Origin ID

D006918;

UMLS CUI

C0020402;

ATC code(s)
- hydroxycarbamide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Hydroxyurea adverse reaction (disorder) [SNOMED CT concept]
- Hydroxyurea poisoning (disorder) [SNOMED CT concept]
- hydrixycarbamide [Substance BNPC]
Currated CISMeF NLP mapping
- Hydroxycarbamide [ICD-11 Extension code]
- Hydroxycarbamide (substance) [SNOMED CT concept]
- Hydroxyurea [NCIt concept]
- hydroxyurea [SNOMED Notion]
- hydroxyurea [International Nonproprietary Name]
Exact mapping(s) to DCI
- hydroxyurea [International Nonproprietary Name]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- antisickling agents [MeSH Descriptor]
- nucleic acid synthesis inhibitors [MeSH Descriptor]
Record concept(s)
- hydrea [MeSH concept]
- hydroxyurea [MeSH concept]
- oncocarbide [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-(4-chlorophenyl)-3-(3-(4-chlorophenyl)-5,5-dimethyl-1-(3-(5-nitrofuran-2-yl)allyldienehydrazinocarbonylmethyl)-2-oxoimidazolidin-4-yl)-1-hydroxyurea [MeSH Supplementary Concept]
- 1-(5,5-dimethyl-3-naphthalen-1-yl-1-(3-(5-nitrofuran-2-yl)allyldienehydrazinocarbonylmethyl)-2-oxoimidazolidin-4-yl)-3-naphthalen-1-yl-1-hydroxyurea [MeSH Supplementary Concept]
- A 78773 [MeSH Supplementary Concept]
- A-VBM-FH6 protocol [MeSH Supplementary Concept]
- BCHE protocol [MeSH Supplementary Concept]
- BFHM protocol [MeSH Supplementary Concept]
- BW B70C [MeSH Supplementary Concept]
- CGS 26529 [MeSH Supplementary Concept]
- CHAMOCA regimen [MeSH Supplementary Concept]
- CHAMOMA protocol [MeSH Supplementary Concept]
- HCOMLA protocol [MeSH Supplementary Concept]
- L-6 protocol [MeSH Supplementary Concept]
- MLL-93 protocol [MeSH Supplementary Concept]
- N-(4-chlorophenyl)-N-hydroxy-N'-(3-chlorophenyl)urea [MeSH Supplementary Concept]
- N-1-(fur-3-ylethyl)-N-hydroxyurea [MeSH Supplementary Concept]
- N-methylzileuton [MeSH Supplementary Concept]
- N4SE protocol [MeSH Supplementary Concept]
- RBx 7796 [MeSH Supplementary Concept]
- TPDC-FuHu protocol [MeSH Supplementary Concept]
- VHCP protocol [MeSH Supplementary Concept]
- atreleuton [MeSH Supplementary Concept]
- caracemide [MeSH Supplementary Concept]
- carbamoyloxyurea [MeSH Supplementary Concept]
- fenleuton [MeSH Supplementary Concept]
- half protocol [MeSH Supplementary Concept]
- methyl hydroxyurea [MeSH Supplementary Concept]
- zileuton [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Hydroxycarbamide [ICD-11 Extension code]
- Hydroxycarbamide (substance) [SNOMED CT concept]
- Hydroxyurea [NCIt concept]
- Product containing hydroxycarbamide (medicinal product) [SNOMED CT concept]
- hydrixycarbamide [Substance BNPC]
- hydroxycarbamide [ATC Code]
- hydroxyurea [International Nonproprietary Name]
- hydroxyurea [SNOMED Notion]
Validated automatic mappings to BTNT
- hydroxycarbamide [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients